Cullinan Therapeutics, Inc. · NASDAQ:CGEM
Cullinan Therapeutics, Inc. shareholders
As of Sep 30, 2026, 174 institutions reported holding Cullinan Therapeutics, Inc. Largest: Mpm Bioimpact LLC, Lynx1 Capital Management LP and Bvf Inc. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cullinan Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Mpm Bioimpact LLC | 9.72M | −10,260 | Nov 16, 2026 | |
| Lynx1 Capital Management LP | 8.96M | no change | Nov 16, 2026 | |
| Bvf Inc | 5.75M | no change | Nov 16, 2026 | |
| BlackRock | 5.32M | +86,547 | Nov 13, 2026 | |
| T. Rowe Price | 4.09M | +266K | Nov 16, 2026 | |
| Vanguard | 3.74M | −50,432 | Nov 13, 2026 | |
| Kynam Capital Management, LP | 3.11M | no change | Nov 16, 2026 | |
| State Street | 2.6M | −1.06M | Nov 12, 2026 | |
| Rtw Investments, LP | 2.36M | no change | Nov 16, 2026 | |
| Siren, L.L.C. | 1.79M | −100K | Nov 12, 2026 |